Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tyra Biosciences, Inc.

10.93
+0.45004.29%
Volume:54.01K
Turnover:580.18K
Market Cap:580.27M
PE:-7.23
High:10.99
Open:10.60
Low:10.50
Close:10.48
Loading ...
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 29, 2025

Major Issues Report

Form 8-K - Current report
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Dec 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 19, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Oct 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities